Inmed Pharmaceuticals Inc (INM)

Jun 13, 2025

Inmed Pharmaceuticals Inc Amends Standby Equity Purchase Agreement With Yorkville - marketscreener.com

Jun 13, 2025

Jun 13, 2025

InMed Announces Auditor Change to CBIZ, Updates SEPA Agreement Terms | INM Stock News - Stock Titan

Jun 13, 2025

Jun 13, 2025

Transcript : InMed Pharmaceuticals Inc.Shareholder/Analyst Call - MarketScreener

Jun 13, 2025

Jun 04, 2025

Best Cannabis Stocks To Follow Now – June 2nd - Defense World

Jun 04, 2025

Jun 02, 2025

Top Premarket Gainers - MarketScreener

Jun 02, 2025

May 30, 2025

New CB1 and CB2 receptor modulators disclosed in Inmed patent - BioWorld MedTech

May 30, 2025

May 27, 2025

InMed Pharmaceuticals Reports Q1 2025 Financial Results - TipRanks

May 27, 2025

May 24, 2025

Registration Now Open For Tribe Public’s Webinar Event "Exploring the Neuroprotective Qualities of Rare Cannabinoids" Featuring InMed’s Management Team On November 17, 2022 - Seeking Alpha

May 24, 2025

May 22, 2025

InMed Pharmaceuticals (NASDAQ:INM) Trading Down 11.5% – Here’s What Happened - Defense World

May 22, 2025

May 16, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

May 16, 2025

May 12, 2025

InMed Pharmaceuticals Advances Drug Pipeline Amid Financial Challenges - TipRanks

May 12, 2025

May 12, 2025

InMed Reports Third Quarter Fiscal 2025 Financial Results and Pr - GuruFocus

May 12, 2025

May 12, 2025

InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update - Newsfile

May 12, 2025

May 12, 2025

InMed Pharmaceuticals Inc. SEC 10-Q Report - TradingView

May 12, 2025

Apr 29, 2025

SEC Form PRE 14A filed by InMed Pharmaceuticals Inc. - Quantisnow

Apr 29, 2025

Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025

Apr 26, 2025

InMed Pharmaceuticals cancels special shareholder meeting By Investing.com - Investing.com Canada

Apr 26, 2025

Apr 25, 2025

InMed Pharmaceuticals cancels special shareholder meeting - Investing.com

Apr 25, 2025

Apr 08, 2025

InMed Pharmaceuticals sets date for special shareholder meeting By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 08, 2025

InMed Pharmaceuticals sets date for special shareholder meeting - Investing.com

Apr 08, 2025

Apr 07, 2025

InMed Pharmaceuticals stock hits 52-week low at $1.72 - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

InMed Pharmaceuticals stock hits 52-week low at $1.72 By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

InMed Pharmaceuticals : Expands on Announcement of Cannabinol (CBN) Therapeutic Leadership with New Website Content and CEO Interview - MarketScreener

Apr 07, 2025

Mar 29, 2025

InMed Pharmaceuticals Stock Hits 52-Week Low at $2.34 By Investing.com - Investing.com India

Mar 29, 2025

Mar 28, 2025

InMed Pharmaceuticals Stock Hits 52-Week Low at $2.34 - Investing.com India

Mar 28, 2025

Mar 05, 2025

InMed Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 05, 2025

Feb 18, 2025

InMed Pharmaceuticals Struggles with Losses Amid Revenue Decline - MSN

Feb 18, 2025

Feb 15, 2025

InMed Pharmaceuticals Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - Defense World

Feb 15, 2025

Feb 14, 2025

InMed Pharmaceuticals Board Reshuffle After Director Resignation - TipRanks

Feb 14, 2025

Feb 13, 2025

InMed to Participate in Upcoming Investor Events - Newsfile

Feb 13, 2025

Feb 13, 2025

InMed Pharmaceuticals Reports Q2 2025 Financial Results - TipRanks

Feb 13, 2025

Feb 12, 2025

InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - Yahoo Finance

Feb 12, 2025

Feb 12, 2025

InMed Pharmaceuticals Inc. (INM) reports earnings - Quartz

Feb 12, 2025

Feb 06, 2025

InMed Advances INM-089 for Dry AMD Treatment with New Intravitreal Formulation - TipRanks

Feb 06, 2025

Feb 04, 2025

Inmed selects IVT formulation of INM-089 for dry AMD - BioWorld Online

Feb 04, 2025

Feb 03, 2025

InMed advances AMD treatment with promising IVT drug formulation - MSN

Feb 03, 2025

Feb 03, 2025

Revolutionary Eye Drug INM-089 Achieves 10X Therapeutic Levels in Macular Degeneration Treatment - StockTitan

Feb 03, 2025

Feb 03, 2025

InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration - Newsfile

Feb 03, 2025

Jan 24, 2025

Inmed Pharmaceuticals Inc (INM-Q) QuotePress Release - The Globe and Mail

Jan 24, 2025

Jan 24, 2025

InMed Pharmaceuticals (NASDAQ: INM) Secures International Patent for Novel Compounds - Defense World

Jan 24, 2025

Jan 22, 2025

InMed Pharmaceuticals Secures Key Patent for Cannabinoid Analogs - TipRanks

Jan 22, 2025

Jan 22, 2025

InMed Pharmaceuticals secures international patent - Investing.com India

Jan 22, 2025

Jan 22, 2025

InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds - Newsfile

Jan 22, 2025

Jan 22, 2025

InMed Secures Breakthrough 20-Year Patent in Mexico for Novel Cannabinoid Compounds - StockTitan

Jan 22, 2025

Jan 22, 2025

Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise - Asianet Newsable

Jan 22, 2025